Postmenopausal Estrogen/Progestin Interventions Explained

The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial was a large randomized controlled trial which assessed the influence of menopausal hormone therapy on cardiovascular and other outcomes.[1] [2] [3] [4]

Notes and References

  1. Barrett-Connor E . Postmenopausal estrogen and heart disease . Atherosclerosis . 118 Suppl . S7–10 . December 1995 . 8821460 . 10.1016/0021-9150(95)90068-3.
  2. Fitzpatrick LA, Good A . Micronized progesterone: clinical indications and comparison with current treatments . Fertil. Steril. . 72 . 3 . 389–97 . September 1999 . 10519605 . 10.1016/s0015-0282(99)00272-1 . free .
  3. Stefanick ML . Estrogen, progestogens and cardiovascular risk . J Reprod Med . 44 . 2 Suppl . 221–6 . February 1999 . 11392036 .
  4. Pike MC . The role of mammographic density in evaluating changes in breast cancer risk . Gynecol. Endocrinol. . 21 . 1–5 . July 2005 . Suppl 1 . 16112948 . 10.1080/09513590400030038 . 39422465 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Postmenopausal Estrogen/Progestin Interventions".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.